Search
for
Sort by
Research 31–60 of 1000+
- Why do some people look older than they should?
- Identification of a novel<i>PNPLA1</i>mutation in a Spanish family with autosomal recessive congenital ichthyosis
- Molecular Genetics of Keratinization Disorders – What’s New About Ichthyosis
- Autosomal recessive congenital ichthyosis due to <i>PNPLA1</i> mutation in a golden retriever–poodle cross‐bred dog and the effect of topical therapy
- Topical polyhydroxy acid treatment for autosomal recessive congenital ichthyosis in the golden retriever: a prospective pilot study
- PHARMACEUTICO- ANALYTICAL AND IN VITRO ANTI-FUNGAL EVALUATION OF POLYHERBAL SHAMPOO IN RELATION TO DANDRUFF
- PHARMACEUTICO- ANALYTICAL AND IN VITRO ANTI-FUNGAL EVALUATION OF POLYHERBAL SHAMPOO IN RELATION TO DANDRUFF
- Using 5 alpha reductase inhibitors safely: What primary care physicians need to know
- Alopecia patterns and trichoscopic findings in patients with autosomal recessive congenital ichthyosis
- Skin barrier, phenotypic and genotypic characterisation of autosomal recessive ichthyosis in TGM1‐deficient Jack Russell Terriers and response to topical ceramide
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- 5α-reductase inhibitors impact prognosis of urothelial carcinoma
- A population‐based nested case–control study: the use of 5‐alpha‐reductase inhibitors and the increased risk of osteoporosis diagnosis in patients with benign prostate hyperplasia
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- 5‐Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety
- Hormonal manipulation of benign prostatic hyperplasia
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors
- Receipt of 5-Alpha Reductase Inhibitors Before Radical Cystectomy: Do They Render High-Grade Bladder Tumors Less Aggressive?
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Macular Abnormalities Associated With 5α-Reductase Inhibitor
- Three Considerations Before Advising 5-α-Reductase Inhibitors for Chemoprevention
- Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- The connection of 5-alpha reductase inhibitors to the development of depression